Core Scientific (CORZ) Free Cash Flow (2021 - 2026)
Core Scientific has reported Free Cash Flow over the past 6 years, most recently at -$139.3 million for Q1 2026.
- Quarterly results put Free Cash Flow at -$139.3 million for Q1 2026, down 8.0% from a year ago — trailing twelve months through Mar 2026 was -$461.1 million (down 126.93% YoY), and the annual figure for FY2025 was -$450.8 million, down 765.74%.
- Free Cash Flow reached -$139.3 million in Q1 2026 per CORZ's latest filing, down from -$121.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $178.3 million in Q4 2022 and bottomed at -$139.3 million in Q1 2026.
- Median Free Cash Flow over the past 5 years was -$26.1 million (2022), compared with a mean of -$33.5 million.
- The largest annual shift saw Free Cash Flow skyrocketed 170.44% in 2023 before it crashed 7656.62% in 2025.
- Over 5 years, Free Cash Flow stood at $178.3 million in 2022, then plummeted by 94.36% to $10.1 million in 2023, then tumbled by 248.67% to -$15.0 million in 2024, then plummeted by 714.14% to -$121.7 million in 2025, then decreased by 14.47% to -$139.3 million in 2026.
- Business Quant data shows Free Cash Flow for CORZ at -$139.3 million in Q1 2026, -$121.7 million in Q4 2025, and -$112.7 million in Q3 2025.